ReviewBiomedicines2022

New Treatment Targets and Innovative Lipid-Lowering Therapies in Very-High-Risk Patients with Cardiovascular Disease.

Achim Leo Burger et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.